About Kanto Rosai Hospital
関東労災病院は神奈川県川崎市中原区に存在する医療機関。独立行政法人労働者健康安全機構が運営する労災病院である。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kanto Rosai Hospital
During the past decade, Kanto Rosai Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
2003-06-01
2019-09-01
Completed
64
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
2003-06-01
2022-12-22
Completed
588
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kanto Rosai Hospital"
#1 collaborator was "Avania" with 1 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "BioClinica, Inc." with 1 trials as a collaborator and "CMIC Co, Ltd. Japan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Kanto Rosai Hospital
According to Clinical.Site data, the most researched conditions in "Kanto Rosai Hospital" are
"Fragility Fracture" (1 trials), "Hip Fractures" (1 trials), "Osteoporosis" (1 trials), "Psoriasis" (1 trials) and "Psoriasis Arthropatica" (1 trials). Many other conditions were trialed in "Kanto Rosai Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kanto Rosai Hospital
Most popular intervention types in "Kanto Rosai Hospital" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "AGN1 LOEP treatment" (1 trials), "Apremilast" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kanto Rosai Hospital
The vast majority of trials in "Kanto Rosai Hospital" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Kanto Rosai Hospital
Currently, there are NaN active trials in "Kanto Rosai Hospital".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Kanto Rosai Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kanto Rosai Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".